Bodyweight reduction of >5% was significantly associated with improved glycated hemoglobin A1c and triglycerides among obese Japanese patients with type 2 diabetes.
Observational
No
Does bodyweight reduction improve cardiovascular disease risk factors in obese Japanese patients with type 2 diabetes?
In obese Japanese patients with type 2 diabetes, a bodyweight reduction of greater than 5% is associated with significant improvements in HbA1c.
AIMS/INTRODUCTION: We aimed to assess the association between bodyweight reduction and cardiovascular disease risk factors, and to identify the minimum bodyweight reduction associated with significant improvement in cardiovascular disease risk factors among obese Japanese patients with type 2 diabetes. MATERIALS AND METHODS: , who visited our clinic between 2013 and 2016. Multivariable linear regression analysis was carried out to assess the relationship between bodyweight changes and glycated hemoglobin A1c, serum lipids and blood pressure. Analyses of covariance were carried out to compare mean changes in cardiovascular disease risk factors across six groups of bodyweight change, 5% bodyweight reduction was associated with improved glycated hemoglobin A1c.
Yoshimura et al. (Wed,) conducted a observational in Obese type 2 diabetes. Bodyweight reduction vs. -1% to <1% bodyweight change was evaluated on Changes in glycated hemoglobin A1c, serum lipids, and blood pressure. Bodyweight reduction of >5% was significantly associated with improved glycated hemoglobin A1c and triglycerides among obese Japanese patients with type 2 diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: